KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Boston Scientific (BSX) FCF Payout Ratio (2020 - 2023)

Boston Scientific's FCF Payout Ratio history spans 4 years, with the latest figure at 0.03 for Q2 2023.

  • For Q2 2023, FCF Payout Ratio fell 60.78% year-over-year to 0.03; the TTM value through Mar 2024 reached 0.01, down 82.07%, while the annual FY2023 figure was 0.02, 73.35% down from the prior year.
  • FCF Payout Ratio for Q2 2023 was 0.03 at Boston Scientific, down from 0.18 in the prior quarter.
  • Across five years, FCF Payout Ratio topped out at 0.18 in Q1 2023 and bottomed at 0.08 in Q1 2022.
  • The 4-year median for FCF Payout Ratio is 0.03 (2020), against an average of 0.04.
  • The largest annual shift saw FCF Payout Ratio plummeted 216.76% in 2022 before it skyrocketed 326.58% in 2023.
  • A 4-year view of FCF Payout Ratio shows it stood at 0.03 in 2020, then soared by 125.13% to 0.06 in 2021, then crashed by 64.37% to 0.02 in 2022, then increased by 24.42% to 0.03 in 2023.
  • Per Business Quant, the three most recent readings for BSX's FCF Payout Ratio are 0.03 (Q2 2023), 0.18 (Q1 2023), and 0.02 (Q4 2022).